Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain : a Double-blind, Crossover, Comparative Study

Centre Hospitalier Universitaire de Saint Etienne1 site in 1 country14 target enrollmentJuly 15, 2022

ConditionsNeuropathic Pain

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Neuropathic Pain
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Enrollment: 14
Locations: 1
Primary Endpoint: Percentage of pain relief
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Epidural stimulation of the primary motor cortex (PMC) is indicated for the relief of neuropathic pain refractory to pharmacological treatment.

Detailed Description

The main objective of this study is to compare the analgesic effect of two distinct waveforms (i.e. tonic versus Burst DR(TM)) delivered by an epidural stimulator of the (primary) motor cortex in patients suffering from neuropathic pain resistant to the best pharmacological treatment.

Registry

clinicaltrials.gov

Start Date

July 15, 2022

End Date

May 15, 2024

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients suffering from neuropathic pain refractory to best pharmacological treatment, operated on for MCS with an internal pulse generator (IPG) capable of delivering both tonic and Burst DR(TM) stimulation waveforms.